Free Trial
NASDAQ:HCWB

HCW Biologics (HCWB) Stock Price, News & Analysis

HCW Biologics logo
$4.04 -0.19 (-4.49%)
Closing price 09/22/2025 04:00 PM Eastern
Extended Trading
$4.04 0.00 (-0.12%)
As of 09/22/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About HCW Biologics Stock (NASDAQ:HCWB)

Advanced

Key Stats

Today's Range
$4.00
$4.22
50-Day Range
$3.31
$6.02
52-Week Range
$2.77
$100.80
Volume
110,760 shs
Average Volume
5.81 million shs
Market Capitalization
$8.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$35.00
Consensus Rating
Buy

Company Overview

HCW Biologics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

HCWB MarketRank™: 

HCW Biologics scored higher than 40% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HCW Biologics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Upside Potential

    HCW Biologics has a consensus price target of $35.00, representing about 766.3% upside from its current price of $4.04.

  • Amount of Analyst Coverage

    HCW Biologics has received no research coverage in the past 90 days.

  • Read more about HCW Biologics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HCW Biologics is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HCW Biologics is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about HCW Biologics' valuation and earnings.
  • Percentage of Shares Shorted

    15.06% of the float of HCW Biologics has been sold short.
  • Short Interest Ratio / Days to Cover

    HCW Biologics has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCW Biologics has recently increased by 542.41%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    HCW Biologics does not currently pay a dividend.

  • Dividend Growth

    HCW Biologics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.06% of the float of HCW Biologics has been sold short.
  • Short Interest Ratio / Days to Cover

    HCW Biologics has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCW Biologics has recently increased by 542.41%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    HCW Biologics has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for HCW Biologics this week, compared to 1 article on an average week.
  • Search Interest

    10 people have searched for HCWB on MarketBeat in the last 30 days. This is an increase of 900% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added HCW Biologics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, HCW Biologics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    42.70% of the stock of HCW Biologics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 2.96% of the stock of HCW Biologics is held by institutions.

  • Read more about HCW Biologics' insider trading history.
Receive HCWB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HCWB Stock News Headlines

This is the “End of Tesla” as we know it…
Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla call alone could have made readers 21 TIMES THEIR MONEY, if they listened to his recommendation. Don't miss his next big prediction.tc pixel
See More Headlines

HCWB Stock Analysis - Frequently Asked Questions

HCW Biologics' stock was trading at $17.8440 at the beginning of the year. Since then, HCWB stock has decreased by 77.4% and is now trading at $4.04.

HCW Biologics Inc. (NASDAQ:HCWB) issued its quarterly earnings results on Monday, August, 18th. The company reported ($6.79) earnings per share (EPS) for the quarter, missing the consensus estimate of $1.80 by $8.59. The business had revenue of $0.01 million for the quarter, compared to analyst estimates of $7 million.

Shares of HCW Biologics reverse split before market open on Friday, April 11th 2025.The 1-40 reverse split was announced on Tuesday, April 1st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 10th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

HCW Biologics (HCWB) raised $45 million in an initial public offering on Tuesday, July 20th 2021. The company issued 5,600,000 shares at a price of $8.00 per share. EF Hutton acted as the underwriter for the IPO and Revere Securities was co-manager.

Top institutional investors of HCW Biologics include Golden State Wealth Management LLC (0.69%). Insiders that own company stock include Hing C Wong, Rebecca Byam, Lee Flowers and Gary M Winer.
View institutional ownership trends
.

Shares of HCWB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that HCW Biologics investors own include Jiuzi (JZXN), Faraday Future Intelligent Electric (FFIE), AMC Entertainment (AMC), Kiora Pharmaceuticals (KPRX), Rallybio (RLYB), Adial Pharmaceuticals (ADIL) and Aridis Pharmaceuticals (ARDS).

Company Calendar

Last Earnings
8/18/2025
Today
9/22/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HCWB
CIK
1828673
Employees
40
Year Founded
2018

Price Target and Rating

High Price Target
$35.00
Low Price Target
$35.00
Potential Upside/Downside
+766.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($14.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$30.02 million
Net Margins
-1,368.55%
Pretax Margin
-1,368.67%
Return on Equity
N/A
Return on Assets
-40.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.11
Quick Ratio
0.11

Sales & Book Value

Annual Sales
$2.57 million
Price / Sales
3.38
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($6.08) per share
Price / Book
-0.66

Miscellaneous

Outstanding Shares
2,150,000
Free Float
1,233,000
Market Cap
$8.69 million
Optionable
Not Optionable
Beta
0.70

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:HCWB) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners